Tao, H., Zhan, Z., Qiu, W., Liao, K., Yuan, Y., Yuan, T., & Zheng, R. (2021). Clinical value of docetaxel plus cisplatin (TP) induction chemotherapy followed by TP concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma. J Cancer.
Citación estilo ChicagoTao, Hao-Yun, Ze-Jiang Zhan, Wen-Ze Qiu, Kai Liao, Ya-Wei Yuan, Tai-Ze Yuan, y Rong-Hui Zheng. "Clinical Value of Docetaxel Plus Cisplatin (TP) Induction Chemotherapy Followed By TP Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma." J Cancer 2021.
Cita MLATao, Hao-Yun, et al. "Clinical Value of Docetaxel Plus Cisplatin (TP) Induction Chemotherapy Followed By TP Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma." J Cancer 2021.